Mandate

Vinge has advised Rotla on the sale of Centralpoint

Vinge advises Rotla B.V., a company controlled by Altor Fund IV and Kool Active B.V.,  in connection with the sale of Centralpoint Holding B.V., the leading IT value added reseller in the Benelux region, to Dustin.

The purchase price amounts to EUR 425 million on a cash and debt free basis and comprises of newly issued shares in Dustin and cash. The sale is subject to customary closing conditions, including merger control clearance from the Dutch competition authority.

Vinge’s team consisted of David Andersson (Capital Markets and Public M&A), Louise Brorsson Salomon and Seyran Sahin (Banking and Finance).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025